Mualliflar

  • Gafurova D.S., Inoyatova F.Kh.

##semicolon##

acute hepatitis, iodine derivative of glycyrrhizic acid, therapeutic dose, hepatoprotector.

##submission.citations##

1. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. Journal of Hepatology. 2019;70(1):151–171. doi:10.1016/j.jhep.2018.09.014.

2. 1. Dikovskiy A.V., Zakirova S.A. Farmatsevticheskaya kompozitsiya dlya lecheniya giperlipidimii. Ru Patent. 2019. Byul. № 10

3. Feingold KR. Cholesterol and Lipoprotein Metabolism. In: Endotext. 2024.

4. Kenneth R. Feingold, MD. The Effect of Endocrine Disorders on Lipids and Lipoproteins 2026

5. Marino L, Kim A, Ni B, Celi FS. Thyroid hormone action and liver disease, a complex interplay. Hepatology. 2023

6. Pastorino G., Cornara L., Soares S. Liquorice (Glycyrrhizaglabra): A phytochemical and phar macological review // Phytotherapy Research. -2018. 32. –P. 2323–2339

7. Ritter MJ, Amano I, Hollenberg AN. Thyroid Hormone Signaling and the Liver. Hepatology. 2020...

8. Sinha R. A., Singh B. K., Yen P. M. (2018). Direct effects of thyroid hormones on hepatic lipid metabolism Nature Reviews Endocrinology, 14(5),259–269.DOI 10.1038/nrendo.2018.10

9. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics

10. Weber LWD, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model 105-136